Showing results (701-710 of 11,014) with videos related to
Sort By:
Pageof 1,102
Human Molecular Genetics|March 1, 1996
Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneityO Bandmann, T G Nygaard, R Surtees, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1986
Familial dystonia and visual failure with striatal CT lucenciesC D Marsden, A E Lang, N P Quinn, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1988
Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disordersD Aubby, H K Saggu, P Jenner, et al.Journal of Chemical Information and Modeling|September 23, 2014
OOMMPPAA: a tool to aid directed synthesis by the combined analysis of activity and structural dataAnthony R Bradley, Ian D Wall, Darren V S Green, et al.European Neurology|January 1, 1987
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's diseaseM H Marion, F Stocchi, S L Malcolm, et al.Acta Crystallographica. Section D, Structural Biology|March 15, 2017
WONKA and OOMMPPAA: analysis of protein-ligand interaction data to direct structure-based drug designCharlotte M Deane, Ian D Wall, Darren V S Green, et al.Journal of Medicinal Chemistry|December 10, 2013
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomainsOleg Fedorov, Hannah Lingard, Chris Wells, et al.Journal of Neurochemistry|March 1, 1990
Mitochondrial complex I deficiency in Parkinson's diseaseA H Schapira, J M Cooper, D Dexter, et al.Plos One|December 2, 2011
Morphological differentiation may mediate mate-choice between incipient species of Anopheles gambiae s.sMichelle R Sanford, Berna Demirci, Clare D Marsden, et al.British Journal of Clinical Pharmacology|March 29, 2012
The absorption and metabolism of a standard oral dose of levodopa in patients with ParkinsonismS Bergmann, G Curzon, J Friedel, et al.Pageof 1,102